Evaluation of efficacy of premix 25% insulin lispro protamine/lispro and premix 50% insulin lispro protamine/lispro on metabolic control in diabetic patients
Objective: We aimed to evaluate the effectiveness of single, two or three additive doses of premixed insulin lispro %25 or three doses of premixed insulin lispro %50 to existing OAD treatments, on HbA1C levels in Type II Diabetics with poor glycemic control. Materials and Methods: 112 patients with Type II DM with HbA1c levels >%7, despite using one or more OAD, and 29 patients with HbA1c levels >%7, despite using premixed insulin lispro %25 and %75 insulin lispro protamin suspension twice a day, and/or one or more OAD, were included in our study. Injectable premixed insulin lispro %25 twice a day was prescribed to patients, whose blood glucose levels didnt regulate at the end of the 3rd month with additive premixed insulin lispro %25 to their existing OAD treatment. At the end of the 6th month, the patients with still unregulated blood glucose levels had premixed insulin lispro %25 or premixed insulin lispro %50 three times a day. The HbA1c levels were checked at 3, 6, and 9th months and compared with the basal levels. Results: %25 of the patients using premixed insulin lispro %25 once a day, 47.5% of the patients using it twice a day, and 77% of the patients using premixed insulin lispro %25 three times a day reached to the HbA1c
The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
We use cookies and other tracking technologies to work properly, to analyze our website traffic, and to understand where our visitors are coming from. More InfoGot It!
